Acquired Bartter-like syndrome, albeit rare, has not been reported to be associated with sarcoidosis. We describe the case of a 32-year-old male patient who presented with progressive muscular weakness of both lower extremities. Profound hypokalaemia associated with renal (K + ) wasting, bilateral nephrocalcinosis and high plasma renin activity resembled Bartter's syndrome (BS). Both mediastinal lymph node and renal biopsy demonstrated sarcoidosis with non-caseating granuloma. Genetic testing responsible for hereditary BS or Gitelman's syndrome (GS) was negative. Hypokalaemia was well controlled with the administration of spironolactone with oral steroids and KCl. Early recognition and prompt treatment of sarcoidosis-associated Bartter-like syndrome avoids unnecessary complications.
Introduction
Bartter's syndrome (BS), a defect in the loop of Henle (LOH), is characterized by chronic hypokalaemia associated with renal K wasting, hypercalciuria and impaired renal concentration. It can be inherited or acquired. Inherited Bartter-like syndrome can be divided into five subtypes: types I-IV are due to a loss of function mutations in the Na/K/Cl co-transporter (NKCC2), ATP-regulated potassium channel (ROMK), kidney-specific basolateral chloride channel (CLCNKB) and β-subunit of the basolateral chloride channel (BSND), and type V is due to a gain of function mutations in calcium-sensing receptors (CASR). Among the acquired causes, diuretic abuse or therapeutic agents such as tuberculostatics (capreomycin and viomycin), amphotericin B, cisplatinum and aminoCorrespondence and offprint requests to: Kuo-Hsiung Shu, Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, 160, Chung-Kang Road, Sec. 3, Taichung, Taiwan. Tel: +886-4-23592525, Ext. 3040; Fax: +886-4-23594980; E-mail: yu5523@yahoo.com.tw glycosides, and autoimmune disease (Sjogren's syndrome) have been reported [1] .
Renal sarcoidosis is a well-known chronic inflammatory disorder characterized by non-caseating granuloma in destructive renal tissues. The clinical features in renal sarcoidosis are protean, including glomrerulonephritis, hypercalciuria, hypercalcaemia, nephrocalcinosis/nephrolithiasis, renal tubular defects and renal failure. To the best of our knowledge, acquired Bartter-like syndrome associated with renal sarcoidosis has not been reported. In this report, we describe a young male patient with acquired Bartter-like syndrome due to renal sarcoidosis, manifesting in hypokalaemia with paralysis.
Case
A 32-year-old male patient was admitted for the evaluation of progressive muscle weakness and polyuria. His birth history revealed a full-term normal birth weight of 3350 g without maternal polyhydramnios. He had experienced persistent polyuria and nocturia for 1 year. He denied recent vomiting, diarrhoea and use of diuretics or herbal medicine.
His body weight was 65 kg and height 166 cm while blood pressure was 110/70 mmHg. Neurological examination revealed diminished deep tendon reflexes with symmetrically areflexia and reduced muscular strength of lower extremities. The remainder of the examination was normal. In addition, profound hypokalaemia (serum K + 1.8 mmol/L) and metabolic alkalosis were the most conspicuous abnormalities in biochemical examination.
Electrocardiogram disclosed a U-wave-like pattern at the same time. Pertinent laboratory studies are shown in Table 1 . Hypokalaemia accompanying inappropriate renal potassium wasting, metabolic alkalosis, persistent low urine osmolality (200 mOsm/kg H 2 O) in response to repeated dDAVP administration, bilateral nephrocalcinosis and hypercalciuria were consistent with BS. A diuretic test was attempted but was prematurely terminated because of profound hypotension during the test. Magnetic resonance image of the brain for neurologic diabetes insipidus caused by neurosarcoidosis was negative. Abdominal sonography clearly showed bilateral nephrocalcinosis. Immune study showed that complement, rheumatoid factor, ANA, anti-ds DNA, anti-SSA/Ro, anti-SSB/La, anti-Smith, ANCA antibodies and snRNP polypeptide U1-70kD were all negative. Chest computed tomography to evaluate the cause of enlarged mediastinum disclosed an abnormal mediastinal lymphadenopathy. Mediastinoscopic biopsy of right-side para-tracheal lymph nodes showed typical non-caseating granulomatous inflammation, consistent with sarcoidosis. Moreover, histology of renal biopsy clearly presented noncaseating granuloma with multinucleated giant cells in the interstitium consistent with granulomatous interstitial nephritis (GIN) (Figure 1 ). Molecular analysis of SLC12A3 for GS, CLCNKB for cBS, and SLC12A1 and KCNJ1 for antenatal BS using peripheral blood genomic DNA of the patient was performed to eliminate the possibility of hereditary BS or Gitelman's syndrome (GS) as previously described. Single-strand conformation polymorphism (SSCP) screening, amplification and direct sequencing of these genes did not reveal any mutations in SLC12A3, SLC12A, KCNJ1, CLCNKB and Barttin [2, 3] . Taken together, inherited BS was less likely, and acquired Bartter-like syndrome due to destructive renal sarcoidosis was considered. Treatment of ACEI and spironolactone (100 mg/day) with predinsolone (30 mg/day) and KCL (64 mmol/day) improved the abnormalities and ameliorated his neurological symptom as well. Follow-up chest film also showed normal pulmonary hilum. 
Discussion
This young patient initially presented with hypokalaemiarelated neuromuscular symptoms and significant polyuria. Laboratory investigations that are ordinarily used to confirm the diagnosis of BS or BS-like syndrome, including plasma renin/aldosterone level, urinary potassium, calcium and magnesium excretion were performed. All the laboratory abnormalities resembled BS, including hypokalaemia with renal (K + ) wasting, metabolic alkalosis, impaired renal concentration ability, hypercalciuria, bilateral nephrocalcinosis and increased plasma rennin-aldosterone activity. BS can be hereditary or acquired. The lack of maternal polyhydramnios and prematurity combined with normal genetic analyses for BS showed a hereditary cause to be unlikely. No other causative factors such as use of diuretics, amphotercin B, cisplatin, aminoglycosides, and autoimmune disease such as Sjogren's syndrome could be identified for acquired BS except the presence of pulmonary and renal sarcoidosis confirmed by typical findings of non-caseating Bartter-like syndrome as an unusual feature of sarcoidosis 669 granuloma; the association of acquired BS with sarcoidosis was highly suggested [4, 5] .
However, hypokalaemia of the patient was improved by therapy with ACEI and spironolactone that do not work in true BS. This may be explained by the fact that the excessive levels of renin and aldosterone plus the high urine volume caused the hypokalaemia, and those high levels were somehow related to the sarcoidosis. Moreover, diminished hypercalciuria in response to steroid treatment with steroid implied that steroids may attenuate vitamin D absorption and in turn, suppressed the absorption of calcium in the intestine. For the investigation of polyuria, persistent low urine osmolality (<150 mOsm/kg) was found despite repeated tests with water restriction; thus, partial nephrogenic DI caused by GIN is highly suspected. Altogether, these clinical features of the patient resembled a rare aetiology of Bartter-like syndrome. Renal manifestations of sarcoidosis are protean and encompass hypercalciuria, hypercalcaemia, nephrolithiasis, nephrocalcinosis, renal tubular defects, glomrerulonephritis and GIN [6] . Hypercalciuria and hypercalcaemia constitute the major problems in renal sarcoidosis, with a prevalence of 40-62% [7] , whereas GIN and renal tubular defects are clinically insidious and ignored frequently. To our knowledge, this is the first case report showing acquired Bartter-like syndrome in renal sarcoidosis.
In the literature reviewed, interestingly, isolated renal tubular dysfunction may be a hallmark of the disease in some patients with sarcoidosis as exemplified in this case. Muther et al. reported 11 cases of sarcoidosis GIN without hypercalcaemia presenting with various derangements in renal tubular functions, including abnormal renal tubular acidification, concentrating defects and significant glycosuria. In addition, Farge et al. reported two cases of sarcoidosis GIN who manifested acquired Fanconi syndrome with persistent tubular dysfunction and significant residual interstitial fibrosis even regression of renal granuloma after steroid therapy [8] .
In regard to therapy, the cornerstone therapy aims at eliminating sarcoidosis with corticosteroids in addition to treatment of hypokalaemia with spironolactone and potassium supplements.
In summary, renal tubular dysfunction caused by renal sarcoidosis can vary greatly. We report the first case resembling BS as a major manifestation of renal sarcoidosis. Early recognition of this association, followed by appropriate treatment should lead to a better outcome.
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